title: MLK3 Signaling in Cancer Invasion.
abstract: Mixed-lineage kinase 3 (MLK3) was first cloned in 1994; however, only in the past decade has MLK3 become recognized as a player in oncogenic signaling. MLK3 is a mitogen-activated protein kinase kinase kinase (MAP3K) that mediates signals from several cell surface receptors including receptor tyrosine kinases (RTKs), chemokine receptors, and cytokine receptors. Once activated, MLK3 transduces signals to multiple downstream pathways, primarily to c-Jun terminal kinase (JNK) MAPK, as well as to extracellular-signal-regulated kinase (ERK) MAPK, P38 MAPK, and NF-κB, resulting in both transcriptional and post-translational regulation of multiple effector proteins. In several types of cancer, MLK3 signaling is implicated in promoting cell proliferation, as well as driving cell migration, invasion and metastasis.
authors.affiliation: Cell and Molecular Biology program, Michigan State University, East Lansing, MI 48824, USA. rattana1@msu.edu.
authors.forename: Chotirat
authors.initials: C
authors.lastname: Rattanasinchai
authors.affiliation: Cell and Molecular Biology program, Michigan State University, East Lansing, MI 48824, USA. gallok@psl.msu.edu.|Department of Physiology, Michigan State University, East Lansing, MI 48824, USA. gallok@psl.msu.edu.
authors.forename: Kathleen A
authors.initials: KA
authors.lastname: Gallo
keywords: cancer invasion; metastasis; mixed lineage kinase 3 (MLK3); signal transduction